Improved detection of rare CALLA-positive cells in peripheral blood using multiparameter flow cytometry.

A major limitation to the detection of rare cell types in the peripheral blood using monoclonal antibodies is nonspecific binding of the antibody reagent to normal cells. Detection of rare common acute lymphoblastic leukemia antigen (CALLA)-positive cells in peripheral blood is significantly improved by using multiple flow cytometric parameters to exclude a variety of mature blood cells which may nonspecifically bind the antibody reagent. Monocytes and granulocytes are excluded by gating out cells with high 90 degrees light scatter. By gating on red fluorescence, a variety of mature cell types binding to phycoerythrin (PE)-conjugated Leu 3, Leu 2, and M3 monoclonal antibodies are also excluded. CALLA-positive lymphoblasts from 6 consecutive patients were not excluded on the basis of these parameters. Gating on log 90 degrees light scatter and log red fluorescence in this fashion reduced the incidence of nonspecific binding to peripheral blood mononuclear cells of a fluorescein-conjugated irrelevant monoclonal antibody by 98% from 308 cells per million to 5 cells per million. One CALLA-positive lymphoblast per 100,000 peripheral blood mononuclear cells could be detected in mixture experiments using this method. The normal range of CALLA-positive cells in adults is less than 16 cells per million peripheral blood mononuclear cells. This low background of CALLA-positive peripheral blood cells may permit the detection of early leukemic relapse in acute lymphoblastic leukemia by analysis of the peripheral blood. This methodology can be applied to the detection of any rare cell type by using phycoerythrin-conjugated antibodies to markers that the cell type does not possess.

[1]  J. Simone Outlook for acute lymphocytic leukemia in children in 1982. , 1981, Annual review of medicine.

[2]  J. Hansen,et al.  Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens , 1983 .

[3]  R. Winchester,et al.  Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies. , 1983, Journal of immunology.

[4]  George R. Buchanan,et al.  Terminal deoxynucleotidyl transferase-containing cells in peripheral blood: implications for the surveillance of patients with lymphoblastic leukemia or lymphoma in remission. , 1981 .

[5]  H. Micklem,et al.  Right angle light scatter: a necessary parameter in flow cytofluorimetric analysis of human peripheral blood mononuclear cells. , 1983, Journal of immunological methods.

[6]  B. Dupont,et al.  Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. , 1983, Blood.

[7]  M. Greaves,et al.  Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic 'lymphoid' cells. , 1980, Leukemia research.

[8]  H. Lazarus,et al.  Distribution and modulation of a human leukemia-associated antigen (CALLA). , 1983, Journal of immunology.

[9]  Clement C. S. Hsu Identification of immunoglobulin isotypes on human B lymphocytes , 1982 .

[10]  T. Powles,et al.  DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCER , 1983, The Lancet.

[11]  Y. Iwatani,et al.  Effects of various isolation methods for human peripheral lymphocytes on T cell subsets determined in a fluorescence activated cell sorter (FACS), and demonstration of a sex difference of suppressor/cytotoxic T cells. , 1982, Journal of immunological methods.

[12]  Greaves Mf,et al.  Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia. , 1981 .

[13]  H. Lazarus,et al.  A monoclonal antibody to human acute lymphoblastic leukaemia antigen , 1980, Nature.

[14]  M. Greaves,et al.  Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. , 1983, Blood.

[15]  T. Lister,et al.  Antisera to acute lymphoblastic leukemia cells. , 1975, Clinical immunology and immunopathology.

[16]  K. Pachmann,et al.  Detection of cALLA positive cells in the human normal peripheral blood by microimmunofluorometry and their fate during cultivation in diffusion chambers. , 2009, Scandinavian journal of haematology.

[17]  S. Stass,et al.  Terminal deoxynucleotidyl transferase immunofluorescence of bone marrow smears: experience in 156 cases. , 1979, American journal of clinical pathology.

[18]  L. Stryer,et al.  Fluorescent phycobiliprotein conjugates for analyses of cells and molecules , 1982, The Journal of cell biology.

[19]  W. Knapp,et al.  Anatomical distribution of call antigen expressing cells in normal lymphatic tissue and in lymphomas. , 1982, Leukemia research.

[20]  Joseph P. Brown,et al.  Detection of melanoma cells in bone marrow using monoclonal antibodies( a comparison of fluorescence activated cell sorting (FACS) and conventional immunofluorescence (IF)) , 1983, Cancer.

[21]  J. Hutton,et al.  Serial observations on terminal deoxynucleotidyl transferase activity and lymphoblast surface markers in acute lymphoblastic leukemia. , 1976, Cancer research.